The University of Massachusetts Lowell (UML) was awarded a $267,696 Project Grant by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to create the PHIT-AR (Addiction Research) track within its existing Public Health Informatics and Technology (PHIT) program. The goal is to recruit and train a diverse group of undergraduate students in data science skills to prepare them for doctoral programs in drug addiction research. The 5-year...
This $2,419,326 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study to investigate neurobehavioral and psychosocial predictors of health risk behaviors (HRBs) in adolescence and young adulthood. The primary awardee, Virginia Polytechnic Institute & State University, will conduct assessments over 15 years to understand brain development and its impact on substance use and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $720,763 to Virginia Commonwealth University (VCU) to investigate the risk and protective factors associated with substance use trajectories in adolescents. The 4-year study will leverage data from the Adolescent Brain Cognitive Development (ABCD) study, which includes a large, nationwide sample of over 11,000 youth, as well as longitudinal...
The National Institute on Drug Abuse (NIDA) awarded a $134,697 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Boston Medical Center Corporation to establish the Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) program. The goal of this 5-year program is to increase the pool of undergraduate scholars prepared to pursue a career path in clinical addiction research. Key program components include: Developing a summer research program for...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $257,522 Project Grant (R25DA061764) to the University of Mississippi to develop a multimodal and interdisciplinary data science training program. The program aims to enhance a diverse workforce for addiction research by providing specialized training in artificial intelligence (AI) and machine learning (ML) methods. Key program components include webinars, summer...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) totaling $1,499,606.00 to the Dartmouth-Hitchcock Clinic, doing business as Dartmouth-Hitchcock Obligated Group, with a project period from September 30, 2024 to July 31, 2029. The goal of this project is to characterize health outcomes from birth to 5 years of age in children born to individuals with opioid use disorder, identify disparities across populations,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), with the official CFDA program title "Drug Use and Addiction Research Programs", is funding the development of an educational intervention to train a diverse workforce in addiction data science. The $136,320 award will support the creation of an immersive, tailored addiction data science skills course that provides hands-on training in areas such as FAIR data principles, computational analytics, and natural...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
The National Institute on Drug Abuse (NIDA) awarded a $300,290 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Minnesota. The 3-year grant, effective August 1, 2025, will fund a summer workshop program to train graduate students and junior researchers on conducting reproducible analysis of brain imaging and genomics data to study the relationship between genetic variants, brain structure/function, and mental health outcomes....